RxDoctor Payments Data

Flavio Arana, MD

Family Medicine · Winter Haven, FLNPI 1326043274

Payments from drug & device makers

$1,514in general payments, 2019–2025

Across 83 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$297
  • AstraZeneca$209
  • Novartis$207
  • Novo Nordisk$204
  • Lilly USA, LLC$105
  • AbbVie$70
  • plus $423 from 13 others

What the payments were for

  • Food & beverage$1,47698%
  • Education$372%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,514 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$192,702
Medicare patients
134
Services billed
15,171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin152$189,840
OzempicSemaglutide80$112,125
EliquisApixaban74$87,539
RybelsusSemaglutide29$54,894
TrulicityDulaglutide39$48,608
MounjaroTirzepatide30$43,737
ArexvyRsvpref3 Antigen/As01e/Pf133$40,826
FarxigaDapagliflozin Propanediol35$37,184
XareltoRivaroxaban33$34,991
EntrestoSacubitril/Valsartan15$23,804
TradjentaLinagliptin18$16,891
KerendiaFinerenone12$14,119
VascepaIcosapent Ethyl20$13,265
ShingrixVaricella-Zoster Ge/As01b/Pf58$12,902
Breo ElliptaFluticasone/Vilanterol18$10,867

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$27$206,731170 claims
Novo NordiskOzempic, Rybelsus$204$167,019109 claims
Lilly USA, LLCTrulicity, Mounjaro$105$92,34569 claims
PfizerEliquis$26$87,53974 claims
GSKArexvy, Shingrix, Breo Ellipta, Anoro Ellipta$53$69,463220 claims
AstraZenecaFarxiga, Symbicort$209$42,19652 claims
Johnson & JohnsonXarelto$44$34,99133 claims
NovartisEntresto$207$23,80415 claims
BayerKerendia$47$14,11912 claims
AbbVieSynthroid$70$1,89629 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Winter Haven

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →